文献速递腹部CT

光谱CT碘图栖息地分析预测胃癌新辅助治疗病理反应

Spectral CT-based habitat analysis for predicting pathologic response to neoadjuvant therapy in gastric cancer.
PubMed 文献 · Eur Radiol · 2026-07-04

回顾性双中心研究纳入151例胃癌患者,新辅助治疗前接受双层光谱CT增强扫描,基于静脉期碘图对肿瘤体素进行k-means聚类。低灌注栖息地体积分数高、异质性评分低者更易为治疗反应者;灌注亚型联合Lauren分型模型内部交叉验证AUC为0.794,外部测试集AUC为0.782。

要点

  • 静脉期碘图上低灌注栖息地体积分数高、ITHscore低的胃癌患者更可能取得新辅助治疗病理反应。
  • 依据低灌注体积分数和ITHscore可将患者分为四种灌注亚型,反应率从75.0%到17.4%不等。
  • 灌注亚型联合Lauren分型可作为新辅助治疗前无创预测病理反应的影像标志物。

核心结论

  • 基于碘图的栖息地成像能够区分不同的灌注亚型,是预测胃癌新辅助治疗病理反应的有前景的方法。

研究设计与样本

  • 回顾性、双中心研究,纳入2022年7月至2025年6月期间经病理确诊并接受新辅助治疗后行胃切除术的151例胃癌患者。
  • 所有患者在新辅助治疗前接受双期对比增强双层光谱CT扫描,研究基于静脉期碘图进行分析。
  • 根据肿瘤退缩分级将患者分为反应者与无反应者,采用k-means聚类将肿瘤体素分为不同栖息地。
  • 计算每个栖息地的体积分数及瘤内异质性评分,采用单因素及logistic回归确定预测参数。
  • 构建加权logistic回归模型预测反应者,采用五折交叉验证及外部测试集进行验证。

关键影像表现/征象

  • 在静脉期碘图上识别出高、中、低三种灌注栖息地。
  • 反应者表现为低灌注栖息地体积分数较高,ITHscore较低。

诊断标准与关键数值

  • 反应者低灌注栖息地体积分数较高、ITHscore较低,差异有统计学意义,均为p<0.05。
  • 联合低灌注栖息地体积分数和ITHscore将患者分为四种灌注亚型,各亚型反应率范围为75.0%至17.4%,p<0.001。
  • 151例患者中54例(35.8%)为病理反应者。

临床应用与阅片要点

  • 静脉期碘图上低灌注体积分数高且异质性评分低的胃癌提示新辅助治疗反应可能性大。
  • 灌注亚型联合Lauren分型可在治疗前无创评估治疗获益概率,辅助个体化治疗决策。
  • 阅片时需注意栖息地分析基于静脉期全病灶体素聚类,建议在专用软件中规范操作步骤。

局限性

  • 研究为回顾性设计,可能存在选择性偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the predictive value of habitat imaging based on spectral CT-derived iodine maps (IMs) for pathologic response to neoadjuvant therapy (NAT) in gastric cancer (GC).

MATERIALS AND METHODS: This retrospective, two-center study included 151 patients with pathologically confirmed GC who underwent NAT followed by gastrectomy between July 2022 and June 2025. All patients underwent dual-phase, contrast-enhanced, dual-layer spectral CT scans before NAT. Based on tumor regression grade, patients were categorized as responders or non-responders. In venous-phase IMs, tumor voxels in the entire lesion were clustered into distinct habitats using the k-means algorithm. The volume fraction of each habitat and an intratumoral heterogeneity score (ITHscore) were calculated. Univariate analysis and logistic regression analyses determined predictive parameters among clinicopathologic and IM-based variables. A weighted logistic regression model for responders was developed and validated using fivefold cross-validation and an external test set.

RESULTS: Among the 151 patients, 54 (35.8%) were responders. Three distinct perfusion habitats (high, middle, and low) were identified. Responders exhibited a higher volume fraction of the low-perfusion habitat and a lower ITHscore (both p < 0.05). By integrating these two metrics, patients were stratified into four perfusion subtypes, with response rates ranging from 75.0% to 17.4% (p < 0.001). The predictive model combining perfusion subtype and Lauren classification achieved an average area under the curve (AUC) of 0.794 (0.751-0.836) in internal cross-validation and 0.782 (0.605-0.909) in the external test set.

CONCLUSION: IM-derived habitat imaging can distinguish distinct perfusion subtypes, suggesting a promising approach for predicting pathologic response to NAT in GC.

KEY POINTS: Question Accurately predicting the efficacy of neoadjuvant therapy prior to treatment in gastric cancer remains challenging due to the lack of reliable biomarkers. Findings Perfusion subtypes identified through iodine map-based habitat imaging effectively predict tumor regression in gastric cancer following neoadjuvant therapy. Clinical relevance Iodine map-based habitat imaging is a promising biomarker for noninvasively predicting pathologic response to neoadjuvant therapy in patients with gastric cancer, thereby enabling more personalized treatment strategies for this population.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. You, Yuan, Yang, et al. Spectral CT-based habitat analysis for predicting pathologic response to neoadjuvant therapy in gastric cancer. Eur Radiol. 2026. PMID: 42401766. doi:10.1007/s00330-026-12727-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。